{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:12:33Z","timestamp":1791389553265,"version":"4.3.3"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA261669"],"award-info":[{"award-number":["P01CA261669"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21 CA241918"],"award-info":[{"award-number":["R21 CA241918"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U19 CA21239"],"award-info":[{"award-number":["U19 CA21239"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011886","name":"Dubai Harvard Foundation for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ijrobp.2023.01.055","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T20:36:09Z","timestamp":1675456569000},"page":"1234-1243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Predictive Model of Liver Toxicity to Aid the Personalized Selection of Proton Versus Photon Therapy in Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7005-8692","authenticated-orcid":false,"given":"Ibrahim","family":"Chamseddine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issam El","family":"Naqa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan G.","family":"Duda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Wolfgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Pursley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Y.","family":"Wo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Paganetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene J.","family":"Koay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-4489","authenticated-orcid":false,"given":"Clemens","family":"Grassberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.01.055_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0002","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jso.21593","article-title":"Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma","volume":"102","author":"Seo","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0003","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000367764","article-title":"Liver-directed radiotherapy for hepatocellular carcinoma","volume":"5","author":"Keane","year":"2016","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0004","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2015.04.006","article-title":"Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma","volume":"115","author":"Huertas","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0011","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2217\/hep.15.7","article-title":"Radiotherapy for liver tumors","volume":"2","author":"Keane","year":"2015","journal-title":"Hepat Oncol"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jhep.2017.02.022","article-title":"Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis","volume":"67","author":"Sapisochin","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0006","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","article-title":"Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"26","author":"Tse","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0007","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12094-010-0492-x","article-title":"Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma","volume":"12","author":"C\u00e1rdenes","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0008","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1002\/cncr.27533","article-title":"Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization","volume":"118","author":"Kang","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0009","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.radonc.2018.12.005","article-title":"Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies","volume":"131","author":"Rim","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0012","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prro.2021.09.004","article-title":"External beam radiation therapy for primary liver cancers: An ASTRO Clinical Practice Guideline","volume":"12","author":"Apisarnthanarax","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0013","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ijrobp.2008.10.073","article-title":"A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma","volume":"74","author":"Fukumitsu","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0014","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"34","author":"Hong","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijrobp.2019.01.076","article-title":"Protons versus photons for unresectable hepatocellular carcinoma: Liver decompensation and overall survival","volume":"105","author":"Sanford","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0016","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijrobp.2017.10.005","article-title":"Modeling of normal tissue complications using imaging and biomarkers after radiation therapy for hepatocellular carcinoma","volume":"100","author":"El Naqa","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0017","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2020.04.027","article-title":"Dosimetric analysis and normal-tissue complication probability modeling of Child-Pugh score and albumin-bilirubin grade increase after hepatic irradiation","volume":"107","author":"Pursley","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0021","article-title":"Predictive modeling of survival and toxicity in patients with hepatocellular carcinoma after radiotherapy","volume":"6","author":"Chamseddine","year":"2022","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0018","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ijrobp.2021.01.042","article-title":"Integrating multiomics information in deep learning architectures for joint actuarial outcome prediction in non-small cell lung cancer patients after radiation therapy","volume":"110","author":"Cui","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0019","unstructured":"Chamseddine I, Kim Y, Paganetti H, Grassberger C. Predicting radiotherapy outcomes in hepatocellular. Available at: https:\/\/osf.io\/6pwgk\/#!. Accessed May 2, 2022."},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0020","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3389\/fonc.2020.00978","article-title":"Registering study analysis plans (SAPs) before dissecting your data\u2014updating and standardizing outcome modeling","volume":"10","author":"Thor","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0022","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4103\/IJPC.IJPC_97_18","article-title":"Effectiveness of the MELD\/Na score and the Child-Pugh score for the identification of palliative care needs in patients with cirrhosis of the liver","volume":"24","author":"Puentes","year":"2018","journal-title":"Indian J Palliative Care"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0023","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/00401706.2020.1791959","article-title":"Ridge regularization: An essential concept in data science","volume":"62","author":"Hastie","year":"2020","journal-title":"Technometrics"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0024","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ijrobp.2017.01.221","article-title":"Predictors of liver toxicity following stereotactic body radiation therapy for hepatocellular carcinoma","volume":"97","author":"Velec","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/0973-1482.19597","article-title":"Analytical approach to estimate normal tissue complication probability using best fit of normal tissue tolerance doses into the NTCP equation of the linear quadratic model","volume":"1","author":"Kehwar","year":"2005","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement","volume":"13","author":"Collins","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0027","doi-asserted-by":"crossref","first-page":"597","DOI":"10.22237\/jmasm\/1257035100","article-title":"New effect size rules of thumb","volume":"8","author":"Sawilowsky","year":"2009","journal-title":"J Modern Appl Stat Methods"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0028","first-page":"3","article-title":"Probabilistic outputs for support vector machines and comparison to regularized likelihood methods","volume":"10","author":"Platt","year":"1999","journal-title":"Advances in large margin classifiers"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1175\/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2","article-title":"Verification of forecasts expressed in terms of probability","volume":"78","author":"Brier","year":"1950","journal-title":"Monthly Weather Rev"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jamia\/ocz228","article-title":"A tutorial on calibration measurements and calibration models for clinical prediction models","volume":"27","author":"Huang","year":"2020","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0031","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1002\/mp.13122","article-title":"Development of deep neural network for individualized hepatobiliary toxicity prediction after liver SBRT","volume":"45","author":"Ibragimov","year":"2018","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0032","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1002\/mp.14235","article-title":"Deep learning for identification of critical regions associated with toxicities after liver stereotactic body radiation therapy","volume":"47","author":"Ibragimov","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0033","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1109\/JBHI.2019.2904078","article-title":"Neural networks for deep radiotherapy dose analysis and prediction of liver SBRT outcomes","volume":"23","author":"Ibragimov","year":"2019","journal-title":"IEEE J Biomed Health Inform"},{"key":"10.1016\/j.ijrobp.2023.01.055_bib0034","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijrobp.2007.05.078","article-title":"Liver function after irradiation based on computed tomographic portal vein perfusion imaging","volume":"70","author":"Cao","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623001049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623001049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:06:50Z","timestamp":1759745210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623001049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0360301623001049"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.01.055","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive Model of Liver Toxicity to Aid the Personalized Selection of Proton Versus Photon Therapy in Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.01.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}